Back to results
US 2025/0019650 A1Published application
Neural cell extracellular vesicles
AssigneesAruna Bio, Inc., University of Georgia Research Foundation, Inc.
InventorsSteven L. Stice, Robin Lynn Webb, Tracey A. Stice
Life of this patent
Estimating the term…
Abstract
Disclosed herein are neural extracellular vesicles (EVs) and methods of using these EVs in the treatment of spinal cord injury, stroke, and traumatic brain injury and neurodegenerative diseases.
Claims15
1-20. (canceled)
A pharmaceutical composition comprising a therapeutically effective amount of extracellular vesicles (EVs) obtained from non-transformed human neural progenitor cells, wherein the EVs comprise macrophage colony-stimulating factor or ecto-5′-nucleotidase (NT5E).
Dependencies are inferred from the claim text.